• Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

1800 Total Publications

Biological heterogeneity in ADNI amnestic mild cognitive impairment
Nettiksimmons, J., DeCarli, C., Landau, S., & Beckett, L.
PMID: 24418061 ; PMCID:4092059 ; 2014; Journal Alzheimer's and Dementia; vol. 10; no. 5; pp. 511-521.e1; AWTYjQFywAl_G9zjEvck doi:10.1016/j.jalz.2013.09.003
Ontology driven decision support for the diagnosis of mild cognitive impairment
Zhang, X., Hu, B., Ma, X., Moore, P., & Chen, J.
PMID: 24468160 ; 2014; Journal Computer Methods and Programs in Biomedicine; vol. 113; no. 3; pp. 781-791; AWTYs7amwAl_G9zjEvfd doi:10.1016/j.cmpb.2013.12.023
Joint Association Discovery and Diagnosis of Alzheimer’s Disease by Supervised Heterogeneous Multiview Learning
Zhe S1, Xu Z, Qi Y, Yu P; ADNI
PMID: 24297556 ; 2014; Journal Pac Symp Biocomput; pp. 300-11; AWTYs7amwAl_G9zjEvfo
Multivariate Analysis of Structural MRI and PET (FDG and 18F- AV-45) for Alzheimer’s Disease and Its Prodromal Stages
Zhou Q, Goryawala M, Cabrerizo M, Barker W, Loewenstein D, Duara R, Adjouadi M
PMID: 25570142 ; 2014; Journal Conf Proc IEEE Eng Med Biol Soc; vol. 2014; pp. 1051-4; AWTYs7amwAl_G9zjEvfp doi:10.1109/EMBC.2014.6943774
Disease progression model for Clinical Dementia Rating-Sum of Boxes in mild cognitive impairment and Alzheimer's subjects from the Alzheimer's Disease Neuroimaging Initiative
Samtani, M. N., Raghavan, N., Novak, G., Nandy, P., & Narayan, V. A.
PMID: 24926196 ; PMCID:4049432 ; 2014; Journal Neuropsychiatric Disease and Treatment; vol. 10; pp. 929-52; AWTYl1zNwAl_G9zjEvdj doi:10.2147/NDT.S62323
Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment
Toledo, J. B., Korff, A., Shaw, L. M., Trojanowski, J. Q., & Zhang, J.
PMID: 25478014 ; PMCID:4255518 ; 2014; Journal Alzheimer's Research and Therapy; vol. 6; no. 3; pp. 36; AWTYmoe0dzjauPDbjhoj doi:10.1186/alzrt266
Alzheimer'sdisease Neuroimaging Initiative1. Amygdalar atrophy in early Alzheimer's disease.
Klein-Koerkamp Y, Heckemann RA, Ramdeen KT, Moreaud O, Keignart S, Krainik A, Hammers A, Baciu M, Hot P;
2014; Journal Current Alzheimer's Research; vol. 11; no. 3; pp. 239-52; AWUVIqi8dzjauPDbjhrU
Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.
Da, X., Toledo, J. B., Zee, J., Wolk, D. a., Xie, S. X., Ou, Y., … Davatzikos, C.
2014; Journal Neuroimage: Clinical; vol. 4; pp. 164-173; AWUVIqi8dzjauPDbjhrY doi:10.1016/j.nicl.2013.11.010
Genetic variation modifies risk for neurodegeneration based on biomarker status.
Hohman, T. J., Koran, M. E. I., & Thornton-Wells, T. A
2014; Journal Frontiers in Aging Neuroscience; vol. 6; pp. 183; AWUVJki0wAl_G9zjEvg6 doi:10.3389/fnagi.2014.00183